Younger donor age (18-35) is crucial for stem cell transplant success and patient survival; superseding related sibling matches and older donor paradigms.
ORLANDO, Dec. 6, 2025) Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma Allogeneic hematopoietic stem cell ...
1.5-year clinical outcomes in patients with triple-mutated AML who were positive and negative for MRD before allo-HSCT. This paper explores the clinical outcomes of allogeneic hematopoietic stem cell ...
Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...
Guwahati: Dr B Borooah Cancer Institute (BBCI) has achieved a medical milestone by performing northeast’s first matched unrelated donor (MUD) allogeneic stem cell transplant. The procedure, which uses ...
The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...
Ruth Wake, 57, said she was told to put her affairs in order but refused to 'accept the decision, give up and ultimately die' ...